Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
MAN-BIOPSY pursues the concrete research question whether novel biological and
psycho-physiological clusters or categories can be defined to improve treatment and minimize
side effects in psychiatry, based on a synopsis of physiological, behavioural, genetic and
endocrinological parameters. One major aspect of our research approach is its focuses on the
identification of dysfunctions in fundamental information processing mechanisms and
neurocomputational mechanisms, and is not restricted to symptom-oriented tasks.
The main objectives of MAN-BIOPSY are therefore
- to identify biological and psycho-physiological parameters for major depressive
disorders and anxiety disorders, and
- to identify predictive markers for treatment response and type/severity of side effects
for these disorders.